Volume 21, Number 6—June 2015
Research
Hospitalization Frequency and Charges for Neurocysticercosis, United States, 2003–2012
Table 2
Number and rate of hospitalizations for neurocysticercosis in the United States, by demographic group, 2003–2012*
Characteristic† | No. hospitalizations (SE) | % All hospitalizations (95% CI) | Rate (95% CI)‡ |
---|---|---|---|
Age, y | |||
<20 | 1,493 (103) | 8.0 (7.1–9.1) | 0.18 (0.16–0.21) |
20–44 | 10,827 (394) | 58.3 (56.5–60.1) | 1.04 (0.97–1.12) |
45–64 | 4,357 (232) | 23.5 (22.0–25.0) | 0.56 (0.51–0.62) |
≥65 |
1,889 (136) |
10.2 (9.0–11.5) |
0.49 (0.42–0.56) |
Sex | |||
M | 10,377 (373) | 56.3 (54.5–58.2) | 0.70 (0.65–0.75) |
F |
8,043 (349) |
43.7 (41.8–45.5) |
0.52 (0.48–0.57) |
Race/ethnicity | |||
Hispanic | 12,030 (551) | 74.0 (71.5–76.3) | 2.50 (2.27–2.73) |
White | 1,530 (104) | 9.4 (8.2–10.7) | 0.07 (0.06–0.08) |
Black | 900 (95) | 5.5 (4.5–6.8) | 0.25 (0.21–0.30) |
Asian/Pacific Islander |
377 (61) |
2.3 (1.7–3.2) |
0.31 (0.23–0.39) |
Overall | 18,584 (644) | 0.61 (0.57–0.66) |
*National estimates were based on the Nationwide Inpatient Sample, by using diagnosis code 123.1 from the International Classification of Diseases, 9th
Revision, Clinical Modification.
†Missing data not presented
‡Rate for age and sex are unadjusted. Rate for race/ethnicity is adjusted for age and sex by direct standardization method by using 2005 US Census data. Rates expressed as mean annual incidence per 100,000 population.